Overview
This guide covers GHK-Cu + Epitalon as a proposed combination. No primary study record of the complete combination is currently attached to this page, so the material here cannot establish an added benefit, a validated combined regimen, or a reliable rate of adverse events. Ingredient studies remain useful background, but they answer narrower questions about the intervention each paper actually tested. The gap described here concerns this guide’s linked sources and is not a claim that the combination has never been studied elsewhere.
Ingredients
- GHK-CuRead the ingredient evidence and its limits.
- EpitalonRead the ingredient evidence and its limits.
The combination examined on this page contains GHK-Cu + Epitalon. Each ingredient needs to be identified by its actual molecule and preparation before research can be matched to the combination. The linked ingredient guides provide a route into that evidence, while ingredients without a dedicated guide remain named explicitly. A shared nickname, similar product label, or premixed presentation cannot establish that every ingredient, concentration, and route matches a published intervention.
Why combine them?
The reason to investigate GHK-Cu + Epitalon together must be separated from evidence that the combination improves an outcome. A plausible role for each ingredient can motivate a study, but it does not show whether their effects complement one another, overlap, or introduce additional problems. The sources attached to this guide do not resolve that comparison for the complete stack. A convincing test would compare the proposed combination with the relevant individual ingredients and measure both the intended benefit and adverse events.
Combination benefits
No effectiveness assessment for the complete GHK-Cu + Epitalon combination has been established from the primary sources attached to this guide. A positive finding for one ingredient cannot determine the size or direction of an effect when other ingredients are added. Claims about improved recovery, symptoms, body composition, or another outcome must be evaluated against what a combination study actually measured. Until that direct assessment is available, the ingredient evidence remains background and the added-benefit question remains unresolved.
Safety & interactions
This page does not establish the safety or interaction profile of GHK-Cu + Epitalon taken together. Assessing that question requires the full formulation, route, exposure, concurrent treatments, and adverse-event reporting from relevant combination research. Tolerability observed with an ingredient alone cannot establish the safety of adding the other ingredients, and missing reports cannot be treated as reassurance. Any proposed clinical use also requires an assessment of the individual’s circumstances rather than a conclusion drawn solely from a stack name.
Forms & dosing
The sources attached to this guide do not establish a validated dose, ingredient ratio, route, or cycle for the complete GHK-Cu + Epitalon combination. A schedule reported for one ingredient remains part of that study’s intervention and should not be combined with a second paper’s schedule to create a new protocol. Formulation and administration details also need to match before results can be applied. Accordingly, reported study amounts are treated as source information rather than a recommendation for using this stack.
Evidence
These assessments describe confidence in a specific outcome for the population and formulation actually studied. Select an outcome or source count to inspect the supporting sources, methods, and limitations before applying a finding to a broader claim. Research on an individual ingredient is kept separate from evidence about a complete stack, and laboratory findings are distinguished from clinical outcomes. An unassessed question remains unresolved; it should not be read as evidence of either effectiveness or ineffectiveness. How we grade evidence.
Research Feed
Studies
Open a study to read its findings and limits, then explore the source passages and PDF details. Numbered citations link to References below.
No study of this exact combination is available in this collection. The studies below concern individual ingredients. Ingredient studies do not establish the benefits or safety of the combination.
A Torilis japonica Extract–GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis
A gene expression signature of emphysemarelated lung destruction and its reversal by the tripeptide GHK
Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu
Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth
Enhanced biological properties of collagen/chitosan‑coated poly(ε‑caprolactone) scaffold by surface modification with GHK‑Cu peptide and 58S bioglass
Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms
Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema and inflammation by reducing oxidative stress pathway
Glycyl-L-histidyl-L-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway
Glycyl- l -histidyl- l -lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro
Human skin penetration of a copper tripeptide in vitro as a function of skin layer
Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy
Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer
In Vitro and in Vivo Studies of pH-Sensitive GHK-Cu-Incorporated Polyaspartic and Polyacrylic Acid Superabsorbent Polymer
In Vivo Stimulation of Connective Tissue Accumulation by the Tripeptide-Copper Complex Glycyl-L-histidyl-L-lysine-Cu2+ in Rat Experimental Wounds
Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application
Mass spectral and theoretical investigations of the transient proton-bound dimers on the cleavage processes of the peptide GHK and its analogues
Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs
The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds
The copper(II)-binding tripeptide GHK, a valuable crystallization and phasing tag for macromolecular crystallography
The glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex attenuates lung inflammation and fibrosis in silicosis by targeting peroxiredoxin 6
The naturally occurring peptide GHK reverses age-related fibrosis by modulating myofibroblast function
The tri-peptide GHK-Cu complex ameliorates lipopolysaccharideinduced acute lung injury in mice
AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism
Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitro
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy
FAQs
Do the ingredient studies prove that the complete stack works?
No effectiveness assessment for the complete GHK-Cu + Epitalon combination has been established from the primary sources attached to this guide. A positive finding for one ingredient cannot determine the size or direction of an effect when other ingredients are added. Claims about improved recovery, symptoms, body composition, or another outcome must be evaluated against what a combination study actually measured. Until that direct assessment is available, the ingredient evidence remains background and the added-benefit question remains unresolved.
Can separate study doses be combined into a stack protocol?
The sources attached to this guide do not establish a validated dose, ingredient ratio, route, or cycle for the complete GHK-Cu + Epitalon combination. A schedule reported for one ingredient remains part of that study’s intervention and should not be combined with a second paper’s schedule to create a new protocol. Formulation and administration details also need to match before results can be applied. Accordingly, reported study amounts are treated as source information rather than a recommendation for using this stack.
Update History
Evidence and review status
- Recorded source check
- Subsequent substantive evidence update
- No later update is recorded for GHK-Cu + Epitalon.
- Independent clinical review
- Pending; this selected-source guide is AI-assisted.
A source-check date is not an exhaustive literature-search cutoff or an independent approval. Adding a paper to the catalogue does not mean its findings have been incorporated into an outcome assessment.
Read the editorial methodReferences
0 sources
This page does not yet have an assessed reference supporting a clinical conclusion about the complete topic. Ingredient links and the broader source library can help locate relevant research, but a related paper is not automatically evidence for the intervention named here. Any future citation needs to be matched to its actual population, formulation, comparison, and outcome. The absence of a reference on this page describes the present review and should not be interpreted as a literature-wide absence of research.
